The top pick for glaucoma is not cannabis. It is prescription intraocular pressure (IOP) care, usually a nightly prostaglandin drop such as latanoprost, and sometimes laser treatment or surgery, chosen and monitored by an ophthalmologist. We compared cannabis and CBD against that standard on four criteria: how long the IOP drop lasts, how predictable it is from dose to dose, the side effect burden, and whether the product could push eye pressure the wrong way. Cannabis loses on all four, and CBD may raise IOP instead of lowering it.
1. Prescription IOP-lowering treatment (the standard of care)
Drops, laser, and surgery are the approaches with long-term evidence that they slow optic nerve damage, not just pressure readings on a single afternoon. Pressure is checked at follow-up visits and the plan is adjusted when it drifts.
Pros
- Controls pressure around the clock, often with one nightly dose
- Decades of outcome data on preserving vision
- Generic prostaglandin drops keep costs manageable for many patients
- Effect is measurable, so your doctor can tell whether it is working
Cons
- Redness, stinging, dry eye, eyelash growth, and iris darkening
- Beta blocker drops can affect heart rate and breathing
- Missed doses mean uncontrolled pressure, and adherence is hard
- Some branded drops and surgical options are expensive
Best for: anyone diagnosed with glaucoma or ocular hypertension. This is the only category with a track record of protecting sight.
2. THC-dominant cannabis (smoked, vaped, or oral)
Smoked and oral THC lower IOP by about 25% in short-term studies. The problem is timing. Pressure falls within an hour or two and returns to baseline in roughly three to four hours, which means dosing every three to four hours, including overnight, to keep pressure down. No study has shown that this pattern prevents vision loss.
Pros
- Produces a real, measurable drop in eye pressure in controlled studies
- Inhaled forms act quickly; oral forms last somewhat longer
- Legal for medical use in many states with a physician recommendation
Cons
- Effect is too short to cover a full day and night
- Intoxication and impaired driving or work performance
- Smoke irritates lungs and airways; blood pressure can drop, raising fall risk in older adults
- Tolerance develops with repeated use
- Dispensary products are not standardized, so dose varies batch to batch
- Researchers have not produced a cannabinoid eye drop that delivers a steady dose
Best for: no glaucoma use case. If you use cannabis for other reasons, tell your eye doctor so it goes in your chart.
3. CBD products
CBD oil, gummies, and tinctures are sold for calm, sleep, and general wellness. For eye pressure, the direction of effect is the concern: multiple animal and small human studies report that CBD can increase IOP rather than lower it.
Pros
- Non-intoxicating and widely available
- May help with sleep or anxiety, which can support overall wellbeing
- Lab-tested brands let you verify what is in the bottle
Cons
- CBD is not an IOP-lowering drug and no regulator has approved it for glaucoma
- Some studies show a rise in eye pressure after CBD
- Oral CBD can interact with medications processed by liver enzymes
- Product labels do not always match actual cannabinoid content
Best for: general wellness, not glaucoma management. If you take high daily doses and have glaucoma, mention it at your next eye exam.
Why duration matters more than the peak number
A single impressive pressure reading does not protect the optic nerve. Glaucoma damage accumulates from pressure that stays elevated across the whole day, especially during sleep, when many people cannot dose. A treatment that lowers pressure for three hours and then lets it climb back leaves most of the day uncovered. That single flaw is why ophthalmology societies do not recommend cannabis for glaucoma, even though the drug does move the number.
What the evidence shows
The American Academy of Ophthalmology states that marijuana is not a recommended glaucoma treatment because the pressure-lowering effect is brief and the side effects outweigh the benefit. The National Eye Institute notes that no scientifically proven delivery method, such as an eye drop, has been developed for cannabis in glaucoma care, and that studies have not shown the drug preserves vision. The FDA has not approved any cannabis product for the treatment of glaucoma.
Safety points for people already using CBD or cannabis
- Keep taking prescribed drops unless your ophthalmologist tells you to stop
- Do not swap a monitored drop regimen for a dispensary product
- Report dizziness, falls, or blood pressure changes to your doctor
- Ask about interactions before adding oral CBD to blood thinners, seizure drugs, or transplant medications
Questions to ask your eye doctor
- What is my target eye pressure, and where am I now?
- Are my current drops controlling pressure overnight?
- Would laser treatment reduce how many drops I need?
- Does anything I take, including CBD, affect my eye pressure?
Bottom line
Cannabis is a poor match for glaucoma because its effect on eye pressure is short, inconsistent, and unproven for protecting vision, and CBD may work against you. Prescription drops, laser, and surgery remain the choices that hold pressure steady and protect the optic nerve. CBD belongs in a wellness routine, not a glaucoma treatment plan.